Literature DB >> 4834709

Tardive and withdrawal dyskinesia associated with haloperidol.

G Jacobson, R J Baldessarini, T Manschreck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4834709     DOI: 10.1176/ajp.131.8.910

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  8 in total

Review 1.  Orofacial dyskinesia. Clinical features, mechanisms and drug therapy.

Authors:  R M Kobayashi
Journal:  West J Med       Date:  1976-10

2.  Dopamine receptors in human and calf brains, using [3H]apomorphine and an antipsychotic drug.

Authors:  P Seeman; M Chau-Wong; J Tedesco; K Wong
Journal:  Proc Natl Acad Sci U S A       Date:  1976-12       Impact factor: 11.205

3.  Psychotic symptoms and a diagnosis of schizophrenia follow an initial diagnosis of tic disorder.

Authors:  Y Fuse-Nagase; M Boku
Journal:  J Psychiatry Neurosci       Date:  1996-11       Impact factor: 6.186

Review 4.  Management of tardive dyskinesia: current update.

Authors:  G M Simpson; E H Pi; J J Sramek
Journal:  Drugs       Date:  1982-05       Impact factor: 9.546

5.  Movement disorders induced in monkeys by chronic haloperidol treatment.

Authors:  B Weiss; S Santelli; G Lusink
Journal:  Psychopharmacology (Berl)       Date:  1977-08-16       Impact factor: 4.530

6.  Clinical aspects of dyskinesia.

Authors:  J Ananth
Journal:  Indian J Psychiatry       Date:  1980-07       Impact factor: 1.759

7.  Amisulpride withdrawal dyskinesia: a case report.

Authors:  Yu-Chi Lo; Ying-Chieh Peng
Journal:  Ann Gen Psychiatry       Date:  2017-06-14       Impact factor: 3.455

8.  Analysis of RNA-protein networks with RNP-MaP defines functional hubs on RNA.

Authors:  Chase A Weidmann; Anthony M Mustoe; Parth B Jariwala; J Mauro Calabrese; Kevin M Weeks
Journal:  Nat Biotechnol       Date:  2020-10-19       Impact factor: 54.908

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.